Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Metrics to compare | CHEK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHEKPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.4x | −5.2x | −0.5x | |
PEG Ratio | −0.01 | −0.25 | 0.00 | |
Price/Book | 0.3x | 3.0x | 2.6x | |
Price / LTM Sales | - | 3.8x | 3.0x | |
Upside (Analyst Target) | - | 19.7% | 54.7% | |
Fair Value Upside | Unlock | −5.0% | 9.3% | Unlock |